Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4005277 | American Journal of Ophthalmology | 2006 | 4 Pages |
Abstract
A single dose of intravitreal pegaptanib was not effective in these two patients at six weeks. This report reminds the ophthalmologist to consider obtaining a fluorescein angiogram during follow-up after an intravitreal pegaptanib injection to monitor CNV lesion characteristics, particularly if the visual acuity decreases.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Adrienne J. MD, Sharon MD, FACS,